Obesity-induced insulin resistance is the fundamental cause of metabolic syndrome.
Accordingly, we evaluated the effect of mangiferin (MGF) on obesity and glucose …

Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease globally. The
progression of NAFLD is complex and associated with inflammation, oxidative stress …

Metabolic syndrome (MetS) represents a considerable clinical and public health burden
worldwide. Mangiferin (MF), a flavonoid compound present in diverse species such as …

Chronic over-nutrition is a major contributor to the spread of obesity and its related metabolic
disorders. Development of therapeutics has been slow compared to the speedy increase in …

This paper was designed to study metabolomic characters of the high-fat diet (HFD)-induced
hyperlipidemia and the intervention effects of Mangiferin (MG). In this study, we aimed to …

One of the main causes of hyperglycemia is inefficient or impaired glucose utilization by
skeletal muscle, which can be exacerbated by chronic high caloric intake. Previously, we …

Mangiferin, a natural C-glucoside xanthone, is one of the major bioactive ingredients
derived from the dry rhizome of Anemarrhenae rhizome, which has been reported to exhibit …

Adipose tissue hypoxia has been recognized as the initiation of insulin resistance
syndromes. The aim of the present study was to investigate the effects of mangiferin on the …

Background Mangiferin (MNG) is known to possess antidiabetic and antioxidant activity.
However, there is no experimental evidence presently available in the literature with regard …

The identification of biologically active and potentially therapeutically useful
pharmacophores from natural products has been a long-term focus in the pharmaceutical …